Рет қаралды 140
Winner of the Health Sciences Prize, ChemoDX has been developed by researchers to help solve the problem of up to 50% of cancer patients receiving unnecessary platinum chemotherapy treatment with a new diagnostic tool that can determine a patient’s likely response to platinum chemotherapy before treatment commences
To find out more about the Curtinnovation Awards: curtin.edu/vnxskk